// Real-Time Intelligence Feed

Financial Intelligence.
Real-Time.

SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.

22,615
Stories Indexed
Live
Feed Status
6
Data Sources
LATEST
AllEarningsFDAM&AInsider TradingRegulatoryOfferingLeadershipRestructuringDividendInstitutional HoldingsBankruptcy
FDA · 22,615 results Live
FDA AVET Feb 19 — 0.00

FDA Approves Unknown Drug — AVET LIFESCIENCES

# FDA Approves AVET Lifesciences Generic Drug Application AVET Lifesciences has received FDA approval for ANDA203276, marking the company's entry into an additional generic drug m…

FDA Micro Feb 17 — 0.00

FDA Approves COLCHICINE — Micro Labs Limited

# FDA Approves Colchicine Generic From Micro Labs Limited Micro Labs Limited received FDA approval for its generic colchicine oral formulation, expanding the competitive landscape…

FDA Janssen Feb 13 — 0.00

FDA Approves RYBREVANT FASPRO — Janssen Biotech, Inc.

# FDA Approves Janssen's RYBREVANT FASPRO Subcutaneous Formulation The FDA has approved Janssen Biotech's RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj), a subcutaneous for…

FDA ZYDUS Feb 12 — 0.00

FDA Approves Unknown Drug — ZYDUS LIFESCIENCES

# FDA Approves Zydus Lifesciences Generic Drug Application Zydus Lifesciences has received FDA approval for ANDA217815, expanding the company's generic drug portfolio and position…

FDA AJENAT Feb 11 — 0.00

FDA Approves GLATIRAMER ACETATE — AJENAT PHARMACEUTICALS LLC

# FDA Approves Generic Glatiramer Acetate for Ajenat Pharmaceuticals Ajenat Pharmaceuticals LLC has received FDA approval for its generic glatiramer acetate injection (ANDA213382)…

FDA Encube Feb 10 — 0.00

FDA Approves TRETINOIN — Encube Ethicals, Inc.

# FDA Approves Encube Ethicals' Generic Tretinoin Topical Formulation The U.S. Food and Drug Administration has approved Encube Ethicals, Inc.'s abbreviated new drug application f…

FDA HIKMA Feb 10 — 0.00

FDA Approves Unknown Drug — HIKMA

On February 10, 2026, Hikma announced regulatory approval for a generic drug through ANDA205057, signaling a strategic precedent for future portfolio initiatives despite the absenc…

FDA Gland Feb 5 — 0.00

FDA Approves ZOLEDRONIC ACID — Gland Pharma Limited

# FDA Approves Gland Pharma's Generic Zoledronic Acid Gland Pharma Limited has received FDA approval for its generic zoledronic acid intravenous formulation, expanding the competi…

FDA Alembic Feb 5 — 0.00

FDA Approves CARBIDOPA, LEVODOPA AND ENTACAPONE — Alembic Pharmaceuticals Inc.

# FDA Approves Generic Carbidopa, Levodopa and Entacapone from Alembic Pharmaceuticals Alembic Pharmaceuticals Inc. received FDA approval for a generic version of carbidopa, levod…

FDA CIPLA Feb 2 — 0.00

FDA Approves Unknown Drug — CIPLA

# FDA Approves CIPLA's Generic Drug Application Cipla Limited received FDA approval for its abbreviated new drug application (ANDA 213165) on February 2, 2026, positioning the com…

FDA Somerset Jan 29 — 0.00

FDA Approves RILPIVIRINE — Somerset Therapeutics, LLC

# FDA Approves Somerset Therapeutics' Generic Rilpivirine Somerset Therapeutics, LLC has received FDA approval for its generic rilpivirine hydrochloride oral formulation (ANDA2187…

FDA Alembic Jan 26 — 0.00

FDA Approves DIFLUPREDNATE — Alembic Pharmaceuticals Inc.

# FDA Approves Generic Difluprednate Ophthalmic from Alembic Pharmaceuticals The FDA has approved Alembic Pharmaceuticals' generic difluprednate ophthalmic formulation, expanding …

FDA NOVITIUM Jan 26 — 0.00

FDA Approves Unknown Drug — NOVITIUM PHARMA

Novitium Pharma secured FDA approval for its ANDA 219119, a milestone anticipated to accelerate revenue generation and strengthen the company's competitive market position.

FDA Novo Dec 22 — 0.00

FDA Approves WEGOVY — Novo Nordisk Pharmaceutical Industries, LP

# FDA Approves Novo Nordisk's Oral Semaglutide (Wegovy) Novo Nordisk Pharmaceutical Industries, LP received FDA approval for the oral formulation of semaglutide (Wegovy) on Decemb…

FDA SpecGx Dec 10 — 0.00

FDA Approves BUPRENORPHINE HCL — SpecGx LLC

On December 10, 2025, SpecGx LLC received FDA approval for the generic sublingual tablet formulation of Buprenorphine Hydrochloride (ANDA 218473), a significant development that is…

FDA Novugen Dec 3 — 0.00

FDA Approves MACITENTAN — Novugen Pharma (USA) LLC

# FDA Approves Generic MACITENTAN from Novugen Pharma The FDA has approved Novugen Pharma's generic version of MACITENTAN, an endothelin receptor antagonist used to treat pulmonar…

FDA Accord Nov 14 — 0.00

FDA Approves LENALIDOMIDE — Accord Healthcare Inc.

# FDA Approves Generic Lenalidomide from Accord Healthcare Inc. Accord Healthcare Inc. received FDA approval for generic lenalidomide (ANDA218872), marking another significant ent…

FDA PAI Nov 14 — 0.00

FDA Approves VORICONAZOLE — PAI Holdings, LLC dba PAI Pharma

# FDA Approves PAI Pharma's Generic Voriconazole Injection PAI Holdings, LLC dba PAI Pharma received FDA approval for its generic voriconazole intravenous injection (ANDA220043), …

FDA Zydus Nov 13 — 0.00

FDA Approves LEUPROLIDE ACETATE — Zydus Pharmaceuticals USA Inc.

# FDA Approves Generic Leuprolide Acetate from Zydus Pharmaceuticals Zydus Pharmaceuticals USA Inc. received FDA approval for generic leuprolide acetate (ANDA215826), marking anot…

FDA Amneal Nov 13 — 0.00

FDA Approves IOHEXOL — Amneal Pharmaceuticals Private Limited

Amneal Pharmaceuticals Private Limited secured FDA approval for its intra-articular formulation of IOHEXOL, positioning the drugmaker to capture market share in the orthopedic nich…